279 top medical experts on Benign Mucous Membrane Pemphigoid across 36 countries and 23 U.S. states, including 148 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Benign Mucous Membrane Pemphigoid: A chronic blistering disease with predilection for mucous membranes and less frequently the skin, and with a tendency to scarring. It is sometimes called ocular pemphigoid because of conjunctival mucous membrane involvement.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Vesiculobullous Skin Diseases (3,611).
  4. Clinical Trials ClinicalTrials.gov : at least 14 including 1 Active, 3 Completed, 4 Recruiting
  5. Synonyms: Cicatricial Pemphigoid


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Foster, Charles Stephen   Ophthalmology   Google Publications
    Massachusetts Eye Research and Surgery Institution MERSI, Waltham, MA.
    Physician  Highly Cited  Highly Published  Case Reports 
    Medical school: Duke University School of Medicine (MD, 1969)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 88/100
    Disclosed payments in 2021 from 46 biomedical companies, totalling $2,442.55, including $1,633.51 from  Bausch & Lomb, a division of Bausch Health US, LLC
    Subjects: Pemphigoid, Benign Mucous Membrane; Conjunctiva; Conjunctival Diseases; Scleritis; Uveitis; Immunosuppressive Agents
    Categories: Drug Therapy; Administration & Dosage; Complications; Metabolism; Pathology; Therapeutic Use
    Mycophenolate mofetil for ocular inflammation. (2010)
    Cyclophosphamide for ocular inflammatory diseases. (2010)

  2. Zone, John J   Dermatology   Google Publications
    Department of Dermatology, University of Utah School of Medicine, Salt Lake City. Top Hospital
    Physician  Highly Published  Case Reports 
    Medical school: University of Utah School of Medicine (MD, 1996)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 100/100
    Subjects: Pemphigoid, Benign Mucous Membrane; Antibodies, Monoclonal, Murine-Derived; Immunoglobulin A; Immunosuppressive Agents
    Categories: Therapeutic Use; Drug Therapy; Diagnosis; Immunology; Therapy
    Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. (2015)
    Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab. (2015)

  3. Thorne, Jennifer E   Ophthalmology   Google Publications
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland. Electronic address: . Top Hospital
    Physician  Highly Cited  Highly Published 
    Disclosed payments in 2021 from 14 biomedical companies, totalling $18,600, including $16,750 from  Gilead Sciences, Inc.
    Subjects: Pemphigoid, Benign Mucous Membrane; Scleritis; Uveitis; Conjunctival Diseases; Immunosuppressive Agents; Anti-Inflammatory Agents, Non-Steroidal
    Categories: Drug Therapy; Complications; Therapeutic Use; Adverse Effects; Analogs & Derivatives; Chemically Induced
    Mycophenolate mofetil for ocular inflammation. (2010)
    Cyclophosphamide for ocular inflammatory diseases. (2010)

  4. Chodosh, James   Ophthalmology  ClinicalTrials.gov Google Publications
    Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts. Top Hospital
    Physician  Highly Published  Case Reports 
    Medical school: Baylor College of Medicine (MD, 1988)
    Medicare Accepted
    Subjects: Pemphigoid, Benign Mucous Membrane; Corneal Diseases; Prostheses and Implants; Prosthesis Implantation; Stevens-Johnson Syndrome; Autoimmune Diseases
    Categories: Surgery; Complications; Enzymology; Metabolism; Etiology; Pathology
    Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid. (2014)
    The Boston keratoprosthesis type I in mucous membrane pemphigoid. (2013)

  5. Payne, Aimee S   Dermatology   Google Publications
    Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Top Hospital
    Physician  Highly Published  Case Reports  Review 
    Medical school: Washington University School of Medicine (MD, 2001)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100
    Disclosed payments from biomedical company (Janssen Research & Development, LLC) in 2021 for $3,100
    Subjects: Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous; Rituximab; Biological Factors; Gingival Diseases; Glucocorticoids
    Categories: Drug Therapy; Administration & Dosage; Therapeutic Use; Therapy
    Clinical outcome and safety of rituximab therapy for pemphigoid diseases. (2020)
    Custom dental trays with topical corticosteroids for management of gingival lesions of mucous membrane pemphigoid. (2020)

  6. Yancey, Kim B   Dermatology  Google Publications
    Department of Dermatology, UT Southwestern Medical Center in Dallas, Dallas, Texas.
    Physician  Highly Cited  Highly Published  Case Reports 
    Medical school: Medical College of Georgia School of Medicine (MD, 1978)
    Medicare Accepted
    Subjects: Pemphigoid, Benign Mucous Membrane; Cell Adhesion Molecules; Mouth Mucosa; Autoantibodies; Autoantigens; Autoimmune Diseases
    Categories: Immunology; Diagnosis; Pathology; Therapeutic Use; Blood; Drug Therapy
    Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. (2015)
    A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid. (2019)

  7. Anesi, Stephen D   Ophthalmology  Google Publications
    Massachusetts Eye Research and Surgery Institution MERSI, Waltham, MA.
    Physician  Highly Published 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 88/100
    Disclosed payments in 2021 from 133 biomedical companies, totalling $106,832.07, including $99,746.25 from  Mallinckrodt Hospital Products Inc.
    Subjects: Pemphigoid, Benign Mucous Membrane; Conjunctiva; Conjunctival Diseases; Adrenocorticotropic Hormone; Immunoglobulins, Intravenous; Immunomodulation
    Categories: Drug Therapy; Administration & Dosage; Diagnosis; Pathology; Therapeutic Use
    Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy. (2019)
    Long-term remission of ocular cicatricial pemphigoid off immunomodulatory therapy. (2018)

  8. Grando, Sergei A   Dermatology  Google Publications
    Department of Dermatology, University of California Irvine, Irvine, CA, USA.
    Physician  Highly Cited  Highly Published  Case Reports  Review 
    Disclosed payments from biomedical company (GENZYME CORPORATION) in 2021 for $300
    Subjects: Pemphigoid, Benign Mucous Membrane; Antibodies, Monoclonal, Murine-Derived; Food; Gastroesophageal Reflux; Gastrointestinal Hemorrhage; Immunoglobulin A
    Categories: Epidemiology; Drug Therapy; Therapeutic Use; Adverse Effects; Diagnosis; Immunology
    Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. (2015)
    World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid. (2015)

  9. Feldman, Ron   Dermatology   Google Publications
    Department of Dermatology, Emory University School of Medicine, Atlanta, GA. . Top Hospital
    Physician  Highly Published  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 85.6/100
    Disclosed payments in 2021 from 4 biomedical companies, totalling $6,200, including $3,100 from  Janssen Research & Development, LLC
    Subjects: Pemphigoid, Benign Mucous Membrane; Autoantibodies; Cornea; Corneal Diseases; Deglutition Disorders; Esophagus
    Categories: Diagnosis; Surgery; Therapeutic Use; Blood; Drug Therapy; Pathology
    Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP). (2016)
    Bilateral keratoprostheses in a patient with ocular mucous membrane pemphigoid. (2019)

  10. Amber, Kyle T   Dermatology   Google Publications
    Division of Dermatology, Rush University Medical Center, Chicago, IL, United States.
    Physician  Highly Published  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 60/100
    Disclosed payments from biomedical company (Almirall LLC) in 2021 for $413
    Subjects: Pemphigoid, Benign Mucous Membrane; Immunoglobulin G; Autoantibodies; Autoantigens; Cell Adhesion Molecules; Cytokines
    Categories: Metabolism; Immunology; Drug Therapy; Epidemiology; Adverse Effects; Standards
    A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA. (2016)
    A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. (2020)

  11. Dohlman, Claes H   Ophthalmology  Google Publications
    Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts. Top Hospital
    Physician  Highly Published  Case Reports 
    Subjects: Pemphigoid, Benign Mucous Membrane; Corneal Diseases; Prostheses and Implants; Prosthesis Implantation; Stevens-Johnson Syndrome; Autoimmune Diseases
    Categories: Surgery; Complications; Enzymology; Metabolism
    Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid. (2014)
    The Boston keratoprosthesis type I in mucous membrane pemphigoid. (2013)

  12. Werth, Victoria P   Dermatology  Google Publications
    Dermatology, Philadelphia V.A. Hospital, Philadelphia, PA, USA.
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100
    Disclosed payments in 2021 from 43 biomedical companies, totalling $77,882.33, including $15,191.5 from  ABBVIE INC.
    Subjects: Pemphigoid, Benign Mucous Membrane; Gingival Diseases; Glucocorticoids; Orthodontic Appliances, Removable
    Categories: Drug Therapy; Administration & Dosage; Diagnosis; Therapy
    Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. (2015)
    Custom dental trays with topical corticosteroids for management of gingival lesions of mucous membrane pemphigoid. (2020)

  13. Fairley, Janet A   Dermatology  Google Publications
    Department of Dermatology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, and Veterans Administration Medical Center, Iowa City, Iowa, U.S.A. Top Hospital
    Physician  Case Reports 
    Medical school: University of Michigan Medical School (MD, 1981)
    Medicare Accepted
    Subjects: Pemphigoid, Benign Mucous Membrane; Autoantibodies; Autoantigens; Glomerulonephritis, Membranous; Non-Fibrillar Collagens
    Categories: Immunology; Blood; Diagnosis; Therapy
    Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. (2015)
    Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII. (2019)

  14. Patel, Payal M   Family Medicine  Google Publications
    Division of Dermatology, Rush University Medical Center, Chicago, IL, United States.
    Physician 
    Subjects: Pemphigoid, Benign Mucous Membrane; Autoantibodies; Autoantigens; Cell Adhesion Molecules; Cytokines; Dermatology
    Categories: Metabolism; Drug Therapy; Immunology; Standards
    A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. (2020)
    Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes. (2021)

  15. Akpek, Esen K   Ophthalmology   Google Publications
    Ocular Surface Diseases and Dry Eye Clinic, Division of Cornea and External Diseases, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: . Top Hospital
    Physician 
    Disclosed payments in 2021 from 32 biomedical companies, totalling $23,706.08, including $15,000 from  Bausch & Lomb, a division of Bausch Health US, LLC
    Subjects: Conjunctivitis; Pemphigoid, Benign Mucous Membrane; Autoimmune Diseases; Cicatrix; Fluorescent Antibody Technique, Direct; Mucous Membrane
    Categories: Diagnosis; Methods; Pathology
    Characterization of Progressive Cicatrizing Conjunctivitis With Negative Immunofluorescence Staining. (2020)
    Mucous membrane pemphigoid: recent advances. (2012)

  16. Freitag, Suzanne K   Ophthalmology  Google Publications
    Ophthalmic Plastic Surgery Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician  Case Reports 
    Medical school: Jefferson Medical College of Thomas Jefferson University (MD, 1994)
    Medicare Accepted
    Disclosed payments in 2021 from 12 biomedical companies, totalling $14,510.61, including $13,762.22 from  Horizon Therapeutics plc
    Subjects: Pemphigoid, Benign Mucous Membrane; Carcinoma, Squamous Cell; Conjunctiva; Conjunctival Neoplasms; Entropion; Eye Diseases
    Categories: Complications; Etiology; Surgery; Methods; Pathology
    Conjunctival Squamous Cell Neoplasia Associated With Ocular Cicatricial Pemphigoid. (2017)
    A conjunctival-sparing surgical technique for lower eyelid cicatricial entropion repair in ocular cicatricial pemphigoid. (2020)

  17. Hall, Russell P   Dermatology  Google Publications
    Dermatology, Duke University, Durham, North Carolina. Top Hospital
    Physician 
    Disclosed payments from biomedical company (Almirall LLC) in 2021 for $650
    Subjects: Pemphigoid, Benign Mucous Membrane; Autoantibodies; Conjunctiva; Conjunctival Diseases; Fluorescent Antibody Technique, Direct
    Categories: Diagnosis; Analysis; Methods; Pathology; Therapy
    Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. (2015)
    Clinical Implications of Direct Immunofluorescence Findings in Patients With Ocular Mucous Membrane Pemphigoid. (2017)

  18. Kempen, John H   Ophthalmology  Google Publications
    Philadelphia, Pennsylvania.
    Physician  Highly Cited  Highly Published 
    Disclosed payments from biomedical company (Gilead Sciences, Inc.) in 2021 for $291.67
    Subjects: Pemphigoid, Benign Mucous Membrane; Scleritis; Uveitis; Immunosuppressive Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctival Diseases
    Categories: Drug Therapy; Therapeutic Use; Adverse Effects; Chemically Induced; Analogs & Derivatives
    Mycophenolate mofetil for ocular inflammation. (2010)
    Cyclophosphamide for ocular inflammatory diseases. (2010)

  19. Rosenbaum, James T   Rheumatology  Google Publications
    Physician  Highly Cited  Highly Published 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100
    Disclosed payments in 2021 from 10 biomedical companies, totalling $21,633.63, including $10,221.75 from  Novartis Pharma AG
    Subjects: Pemphigoid, Benign Mucous Membrane; Scleritis; Uveitis; Immunosuppressive Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctival Diseases
    Categories: Drug Therapy; Therapeutic Use; Adverse Effects; Analogs & Derivatives; Chemically Induced
    Mycophenolate mofetil for ocular inflammation. (2010)
    Cyclophosphamide for ocular inflammatory diseases. (2010)

  20. Suhler, Eric B   Ophthalmology  Google Publications
    Physician  Highly Cited  Highly Published 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 80.3/100
    Subjects: Pemphigoid, Benign Mucous Membrane; Scleritis; Uveitis; Immunosuppressive Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctival Diseases
    Categories: Drug Therapy; Therapeutic Use; Adverse Effects; Analogs & Derivatives; Chemically Induced
    Mycophenolate mofetil for ocular inflammation. (2010)
    Cyclophosphamide for ocular inflammatory diseases. (2010)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);